Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Urologic Neoplasms 01. September 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9057  Previews Next
   
   Articles 1 - 20 / 181123  
   
Practical consensus document on the use of [¹⁷⁷Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer.
Rev Esp Med Nucl Imagen Mol (Engl Ed)
lvarez Mena N, Gmez-Grande A, Nogareda Seoane Z, Prado Wohlwend S, Rodrguez Fernndez A, Rodrguez Fraile M, Vercher Conejero JL, Mitjavila Casanovas M.
PMID: 42674318 [PubMed - as supplied by publisher]


[HIFU: Best Practices for Optimal Performance].
Aktuelle Urol
Salomon G, Heckmann N, Hohenhorst JL, Ekrutt J, Palec J, Nagaraj Y.
PMID: 42673977 [PubMed - indexed for MEDLINE]


[Focal Therapy for Prostate Cancer in Germany: Progress or Illusion?].
Aktuelle Urol
Schostak M, Borkowetz A.
PMID: 42673976 [PubMed - indexed for MEDLINE]


[Which Focal Therapy for Whom and When?].
Aktuelle Urol
Borkowetz A, Schostak M.
PMID: 42673975 [PubMed - indexed for MEDLINE]


Comparative cost-effectiveness of robot-assisted versus open prostatectomy: a real-life nationwide study.
J Robot Surg
Praubert N, Bnard A, Blin P, Jov J, Bladou F, Piazza L, Robert G.
PMID: 42671716 [PubMed - indexed for MEDLINE]


Three-dimensional image guidance using instrument tracking facilitates intraoperative resection-line determination during robot-assisted partial nephrectomy.
J Robot Surg
Tsukino K, Kobayashi S, Koura M, Takamatsu D, Nagakawa S, Tsukahara S, Tanegashima T, Matsumoto T, Shiota M, Oki E, Eto M.
PMID: 42671671 [PubMed - indexed for MEDLINE]


Pelvic floor muscle training for erectile function in men undergoing radical prostatectomy: a systematic review of randomized controlled trials.
World J Urol
Akdagcik Z, Aybal H, Karaaslan M, Guven S, Tunc L, Yilmaz M.
PMID: 42671634 [PubMed - indexed for MEDLINE]


Black Race Predicts Poor Compliance and Higher Prostate Cancer Risk in a Multinational Repeat Biopsy Cohort: Secondary Analysis From the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Clinical Trial.
Prostate
Freedland AR, Moriera DM, Gong J, Freedland SJ.
PMID: 42671204 [PubMed - as supplied by publisher]


Long-Term Oncologic Outcomes of Neoadjuvant Tumor-Directed Immunotherapy (PROSTVAC) Before Radical Prostatectomy for Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Trial.
Prostate
Millan B, Kenigsberg AP, Hesswani C, Koller CR, Parikh SH, Blake Z, Fu H, Blachman-Braun R, Michael P, Gurram S, Turkbey B, Parnes H, Karzai F, Donahue RN, Schlom J, Gulley J, Pinto PA.
PMID: 42671172 [PubMed - as supplied by publisher]


Comparative Prognostic Impact of Two-Dimensional and Three-Dimensional Computed Tomography-Based Sarcopenia Indices in Metastatic Castration-Sensitive Prostate Cancer.
Int J Urol
Hori T, Iwamoto H, Inaba T, Nakagawa R, Kamijima T, Kano H, Makino T, Naito R, Kadomoto S, Yaegashi H, Shigehara K, Nohara T, Izumi K, Mizokami A.
PMID: 42670789 [PubMed - indexed for MEDLINE]


Comparative analysis of surgical outcomes: open versus robot-assisted radical prostatectomy.
Scand J Urol
Olsen RG, Brasso K, Rder A, Konge L, Bjerrum F, Stroomberg HV.
PMID: 42670671 [PubMed - indexed for MEDLINE]


Proton Therapy for Muscle-Invasive Bladder Cancer: Outcomes from the Multicenter Proton Collaborative Group PCG 001-09 Registry Trial.
Cureus
Oska C, Mehta KJ, Simone CB 2nd, Hsieh K, Garg MK, Tang J, Chhabra AM, Choi JI, Chang JH, Thukral AD Jr, Durci M, Nichols EM, Grover R, Gray J, Yacoub I.
PMID: 42670565 [PubMed]


Salvage Re-transurethral Resection of Prostate as a Diagnostic and Therapeutic Bridge in Treatment-Emergent Neuroendocrine Prostate Cancer: A Multimodal Management Paradigm.
Cureus
Kandhan L L, Korrapati VR, Yedulla Reddy R, Palaniyandi V, Sekar H, Krishnamoorthy S.
PMID: 42670457 [PubMed]


Chronic Kidney Disease in Children Within Five Years After Ifosfamide Chemotherapy for Childhood Cancer: A Dutch Pediatric Oncology Cohort Study.
Cancer Med
Pitlo L, Wens FSPL, Raymakers-Janssen PAMA, Haveman LM, Merks JHM, van Grotel M, Janssens GO, Fiocco M, van den Heuvel-Eibrink MM, van den Berg G.
PMID: 42670233 [PubMed - indexed for MEDLINE]


Editorial Comment to Validation of the NCCN Subclassification for Intermediate-Risk Prostate Cancer in a Japanese Radical Prostatectomy Cohort: Results From the MICAN Study.
Int J Urol
Kobayashi S.
PMID: 42669948 [PubMed - in process]


GSTM4 Suppresses Prostate Cancer Progression by Targeting TRIM27-mediated ACLY Ubiquitination and Lipid Metabolism.
Adv Sci (Weinh)
Xiong KP, Liu F, Wang W, Wang G, Qian KY, Tu S, Chen SM, Xu HM, Zhang SS, Li Y, Wang XH, Weng H.
PMID: 42669779 [PubMed - as supplied by publisher]


Identifying Patients With Prostate Cancer Who Benefit Most From Routine Cardiovascular Specialist Referral.
JACC CardioOncol
Cano Garcia C, Pinthus J, Avezum A, Devereaux PJ, Klotz L, Higano C, Fradet V, Selvanayagam J, Guha A, Hajjar L, Lopez-Lopez JP, Xavier D, Ng K, Rangarajan S, Karampatos S, Agapay S, Mian R, Balasubramanian K, Cirne F, Huynh M, Davis MK, Hamilton RJ, Gopaul D, Mukherjee SD, Farooqi M, Benz AP, Richard R, Koo CYC, Leong DP, RADICAL PC Investigators.
PMID: 42669076 [PubMed - as supplied by publisher]


Prognostic significance of systemic immunoinflammatory biomarkers and pathological features in clear cell renal cell carcinoma: a multicenter study.
Ann Med
Yu Z, Yang J, Lv X, Zhang J, Chen D.
PMID: 42669053 [PubMed - indexed for MEDLINE]


Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial.
JAMA Intern Med
Leong DP, Higano C, Cano Garcia C, Fradet V, Siemens DR, Niazi T, Shayegan B, Guha A, Cirne F, Selvanayagam JB, Violette PD, Valle FH, Lavalle LT, Duceppe E, Anderson P, Xavier D, Lopez-Lopez JP, Villareal Trujillo N, Galapo Kann A, Piccoli RK, Mourtzakis M, Sarid D, Narasimha S, Luke PPW, Hajjar LA, Lukka H, Klotz L, Balasubramanian K, Mian R, Agapay S, Rangarajan S, Karampatos S, Ng KKH, Avezum A, Devereaux PJ, Pinthus JH, RADICAL PC Investigators.
PMID: 42669035 [PubMed - as supplied by publisher]


Clinico-genomic risk stratification for biomarker-enriched trial design in poor-prognosis metastatic castrate-resistant prostate cancer (mCRPC).
J Liq Biopsy
Kohli M, Wang L, Tan AC, Fadlullah MZ, Shankar A, Mandrekar SJ, Haaland B.
PMID: 42668516 [PubMed]


   
   Articles 1 - 20 / 181123    Page 1 of 9057  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1